Skip to main content
Top
Published in: Rheumatology International 6/2008

01-04-2008 | Original Article

Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity

Authors: Bożena Targońska-Stępniak, Maria Majdan, Magdalena Dryglewska

Published in: Rheumatology International | Issue 6/2008

Login to get access

Abstract

Leptin is a peptide hormone with the tertiary structure of a cytokine, which not only regulates body weight by inhibiting food intake, but also modulates inflammatory and immune responses. The aim of the study was to investigate if there are connections between leptin concentrations and parameters of nutritional status and disease activity in a group of rheumatoid arthritis (RA) patients. The study group consisted of 37 patients. The mean leptin serum concentration was significantly higher in women than in men. The leptin concentrations correlated positively with BMI only in women with RA. The leptin concentrations were significantly higher in patients with erosive RA. Assessing the group of patients with long-standing RA (duration > 10 years), we found that leptin levels were significantly higher in patients with higher disease activity than in those with DAS28 ≤ 5,1; there was also a positive correlation between serum leptin concentration and the value of DAS28, ESR and the number of tender joints. The results suggest that some important dependence exists between the risk of aggressive course of RA and increased leptin levels.
Literature
2.
go back to reference Walsmith J, Abad L, Kehayias J, Roubenoff R (2004) Tumor necrosis factor-α production is associated with less body mass in women with rheumatoid arthritis. J Rheumatol 31:23–29PubMed Walsmith J, Abad L, Kehayias J, Roubenoff R (2004) Tumor necrosis factor-α production is associated with less body mass in women with rheumatoid arthritis. J Rheumatol 31:23–29PubMed
3.
go back to reference Otero M, Lago R, Gómez R, Lago F, Dieguez C, Gómez-Reino JJ, Gualillo O (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65:1198–1201PubMedCrossRef Otero M, Lago R, Gómez R, Lago F, Dieguez C, Gómez-Reino JJ, Gualillo O (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65:1198–1201PubMedCrossRef
4.
go back to reference Escalante A, Haas RW, del Rincon I (2005) Paradoxical effect of body mass index on survival in rheumatoid arthritis. Arch Intern Med 165:1624–1629PubMedCrossRef Escalante A, Haas RW, del Rincon I (2005) Paradoxical effect of body mass index on survival in rheumatoid arthritis. Arch Intern Med 165:1624–1629PubMedCrossRef
5.
go back to reference Otero M, Lago R, Gómez R, Lago F, Gómez-Reino JJ, Gualillo O (2006) Leptin: a metabolic hormone that functions like a proinflammatory adipokine. Drug News Perspect 19:21–26PubMedCrossRef Otero M, Lago R, Gómez R, Lago F, Gómez-Reino JJ, Gualillo O (2006) Leptin: a metabolic hormone that functions like a proinflammatory adipokine. Drug News Perspect 19:21–26PubMedCrossRef
6.
go back to reference Šenolt L, Housa D, Vernerová Z, Jirásek T, Svobodová R, Veigl D, Anderlová K, Müller-Ladner U, Pavelka K, Haluzik M (2007) Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 66:458–463PubMed Šenolt L, Housa D, Vernerová Z, Jirásek T, Svobodová R, Veigl D, Anderlová K, Müller-Ladner U, Pavelka K, Haluzik M (2007) Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 66:458–463PubMed
7.
go back to reference Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M (2006) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J 99:1078–1083PubMed Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M (2006) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J 99:1078–1083PubMed
8.
go back to reference Majdan M, Kotarski J, Książek A (1999) Evaluation of the relationship between possible control of anemia in hemodialysis patients and the concentration of leptin. Pol Arch Med Wewn 101:295–300PubMed Majdan M, Kotarski J, Książek A (1999) Evaluation of the relationship between possible control of anemia in hemodialysis patients and the concentration of leptin. Pol Arch Med Wewn 101:295–300PubMed
9.
go back to reference Meyers JA, McTiernan A, Ulrich CM (2005) Leptin and immune function: integrating the evidence. Nutr Res 25:791–803CrossRef Meyers JA, McTiernan A, Ulrich CM (2005) Leptin and immune function: integrating the evidence. Nutr Res 25:791–803CrossRef
10.
go back to reference Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Gómez-Reino JJ, Gualillo O (2005) Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579:295–301PubMedCrossRef Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Gómez-Reino JJ, Gualillo O (2005) Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579:295–301PubMedCrossRef
11.
go back to reference Bernotiene E, Palmer G, Gabay C (2006) The role of lepin in innate and adaptive immune response. Arthritis Res Ther 8:217–226PubMedCrossRef Bernotiene E, Palmer G, Gabay C (2006) The role of lepin in innate and adaptive immune response. Arthritis Res Ther 8:217–226PubMedCrossRef
12.
go back to reference Wisłowska M, Rok M, Jaszczyk B, Stępień K, Cicha M (2007) Serum leptin in rheumatoid arthritis. Rheumatol Int 27:947–954PubMedCrossRef Wisłowska M, Rok M, Jaszczyk B, Stępień K, Cicha M (2007) Serum leptin in rheumatoid arthritis. Rheumatol Int 27:947–954PubMedCrossRef
14.
15.
go back to reference Busso N, So A, Chobaz-Peclat V, Morard C, Martinez-Soria E, Talabot-Ayer D, Gabay C (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168:875–882PubMed Busso N, So A, Chobaz-Peclat V, Morard C, Martinez-Soria E, Talabot-Ayer D, Gabay C (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168:875–882PubMed
16.
go back to reference Fraser DA, Thoen J, Reseland JE, Forre O, Kjeldsen-Kragh J (1999) Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 18:394–401PubMedCrossRef Fraser DA, Thoen J, Reseland JE, Forre O, Kjeldsen-Kragh J (1999) Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 18:394–401PubMedCrossRef
17.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
18.
go back to reference Steinbrocker O, Treger H, Cornelius H (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662 Steinbrocker O, Treger H, Cornelius H (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662
19.
go back to reference Mangge H, Liebmann P, Tanil H, Herrmann J, Wagner C, Gallistl S, Schauenstein K, Erwa W (2000) Cystatin C, an early indicator for incipient renal disease in rheumatoid arthritis. Clin Chim Acta 300:195–202PubMedCrossRef Mangge H, Liebmann P, Tanil H, Herrmann J, Wagner C, Gallistl S, Schauenstein K, Erwa W (2000) Cystatin C, an early indicator for incipient renal disease in rheumatoid arthritis. Clin Chim Acta 300:195–202PubMedCrossRef
20.
go back to reference Buettner R, Bollheimer LC, Zietz B, Drobnik W, Lackner K, Schmitz G, Schölmerick J, Palitzsch KD (2002) Definition and characterization of relative hypo- and hyperleptinemia in a large Caucasian population. J Endocrinol 175:745–756PubMedCrossRef Buettner R, Bollheimer LC, Zietz B, Drobnik W, Lackner K, Schmitz G, Schölmerick J, Palitzsch KD (2002) Definition and characterization of relative hypo- and hyperleptinemia in a large Caucasian population. J Endocrinol 175:745–756PubMedCrossRef
21.
go back to reference Anders H, Rihl M, Heufelder A, Loch O, Schattenkirchner M (1999) Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 48:745–748PubMedCrossRef Anders H, Rihl M, Heufelder A, Loch O, Schattenkirchner M (1999) Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 48:745–748PubMedCrossRef
22.
go back to reference Nishiya K, Nishiyama M, Chang A, Shinto A, Hashimoto K (2002) Serum leptin levels in patients with rheumatoid arthritis are correlated with body mass index. Rinsho Byori 50:524–527PubMed Nishiya K, Nishiyama M, Chang A, Shinto A, Hashimoto K (2002) Serum leptin levels in patients with rheumatoid arthritis are correlated with body mass index. Rinsho Byori 50:524–527PubMed
23.
go back to reference Popa C, Netea MG, Radstake TRDS, van Riel PL, Barrera P, van der Meer JWM (2005) Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 64:1195–1198PubMedCrossRef Popa C, Netea MG, Radstake TRDS, van Riel PL, Barrera P, van der Meer JWM (2005) Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 64:1195–1198PubMedCrossRef
24.
go back to reference Hizmetli S, Kisa M, Gokalp N, Bakici MZ (2007) Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? Rheumatol Int 27:335–338PubMedCrossRef Hizmetli S, Kisa M, Gokalp N, Bakici MZ (2007) Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? Rheumatol Int 27:335–338PubMedCrossRef
25.
go back to reference Tokarczyk-Knapik A, Nowicki M, Wyroślak J (2002) The relation between plasma leptin concentration and body fat mass in patients with rheumatoid arthritis. Pol Arch Med Wewn 108:761–767PubMed Tokarczyk-Knapik A, Nowicki M, Wyroślak J (2002) The relation between plasma leptin concentration and body fat mass in patients with rheumatoid arthritis. Pol Arch Med Wewn 108:761–767PubMed
26.
go back to reference Bokarewa M, Bokarew D, Hultgren O, Tarkowski A (2003) Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 62:952–956PubMedCrossRef Bokarewa M, Bokarew D, Hultgren O, Tarkowski A (2003) Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 62:952–956PubMedCrossRef
27.
go back to reference Toussirot E, Nguyen NU, Dumoulin G, Aubin F, Cedoz JP, Wendling D (2005) Relationship between growth hormone-IGF-1–IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford) 44:120–125CrossRef Toussirot E, Nguyen NU, Dumoulin G, Aubin F, Cedoz JP, Wendling D (2005) Relationship between growth hormone-IGF-1–IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford) 44:120–125CrossRef
28.
go back to reference Salazar-Paramo M, Gonzalez-Ortiz M, Gonzalez-Lopez L, Sanchez-Ortis A, Valera-Gonzalez IC, Martinez-Abundis E, Balcazar-Munoz BR, Garcia-Gonzalez A, Gamez-Nava JI (2001) Serum leptin levels in patients with rheumatoid arthritis. J Clin Rheumatol 7:57–59PubMedCrossRef Salazar-Paramo M, Gonzalez-Ortiz M, Gonzalez-Lopez L, Sanchez-Ortis A, Valera-Gonzalez IC, Martinez-Abundis E, Balcazar-Munoz BR, Garcia-Gonzalez A, Gamez-Nava JI (2001) Serum leptin levels in patients with rheumatoid arthritis. J Clin Rheumatol 7:57–59PubMedCrossRef
29.
go back to reference Hörle P, Sarzi-Puttini P, Cutolo M, Straub RH (2006) No change of serum levels of leptin and adiponectin during anti-tumor necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis 65:970–971CrossRef Hörle P, Sarzi-Puttini P, Cutolo M, Straub RH (2006) No change of serum levels of leptin and adiponectin during anti-tumor necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis 65:970–971CrossRef
30.
go back to reference Bruun JM, Pedersen SB, Kristensen K, Richelsen B (2002) Effects of proinflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cel Endocrinol 190:91–99CrossRef Bruun JM, Pedersen SB, Kristensen K, Richelsen B (2002) Effects of proinflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cel Endocrinol 190:91–99CrossRef
Metadata
Title
Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity
Authors
Bożena Targońska-Stępniak
Maria Majdan
Magdalena Dryglewska
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0480-9

Other articles of this Issue 6/2008

Rheumatology International 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine